A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
Titel:
A phase II, randomized, multicenter study evaluating the combination of lapatinib and vinorelbine in women with ErbB2 overexpressing metastatic breast cancer
Auteur:
Janni, Wolfgang Sarosiek, Tomasz Karaszewska, Boguslawa Pikiel, Joanna Staroslawska, Elzbieta Potemski, Piotr Salat, Christoph Brain, Etienne Caglevic, Christian Briggs, Kathryn DeSilvio, Michelle Marini, Luca Papadimitriou, Christos